current user: public




3eljA
Query: 3elj_A mol:protein length:369 Mitogen-activated protein kinase 8, from PDB0312

Results of FFAS03 search in PDB0312
Master-slave alignment does not show gaps in the query sequence, use ali links to display alignment between query and templates.
    .   10    .   20    .   30    .   40    .   50    .   60    .   70    .   80    .   90    .  100    .  110    .  120    .  130    .  140    .  150    .  160    .  170    .  180    .  190    .  200    .  210    .  220    .  230    .  240    .  250    .  260    .  270    .  280    .  290    .  300    .  310    .  320    .  330    .  340    .  350    .  360    .
# Score Template Links and tools%idFirst GPLGSMSRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVMDLELast
1 -145.0003elj_A mol:protein length:369 Mitogen-activated protein kinase 8  ali model  100  1GPLGSMSRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVMDLE 369
2 -143.0002g01_A mol:protein length:370 Mitogen-activated protein kinase 8  ali model follow..  99  1.....MSRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVMDLE 364
3 -143.0002xrw_A mol:protein length:371 MITOGEN-ACTIVATED PROTEIN KINASE 8  ali model follow..  97  3......SRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVMDLE 365
4 -143.0003npc_A mol:protein length:364 Mitogen-activated protein kinase 9  ali model follow..  83  1.....MSKSKVDNQFYSVEVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVRNYVENRPKYPGIKFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPAEAEAPPPQIYDAQLEEREHAIEEWKELIYKEVMDWE 364
5 -142.0002xs0_A mol:protein length:386 MITOGEN-ACTIVATED PROTEIN KINASE 8  ali model follow..  97  1...GSMSRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVMDLE 366
6 -142.0003e7o_A mol:protein length:360 Mitogen-activated protein kinase 9  ali model follow..  83  1.......GSHMDSQFYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVRNYVENRPAYPGIAFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPAEAEAPPPQIYDAQLEEREHAIEEWKELIYKEVMD.. 360
7 -139.0003fv8_A mol:protein length:355 Mitogen-activated protein kinase 10  ali model follow..  93  1.....MSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAXXX---------XXDEREHTIEEWKELIYKEVMNSE 355
8 -125.0003oz6_A mol:protein length:388 Mitogen-activated protein kinase 1, serine/th  ali model follow..  34  2.....................RVDRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSHENIVNLLNVLRA----DNDRDVYLVFDYMETDLHAVIRNILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVDQPILTDYVATRWYRAPEILLGSKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESISPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIPINDNVKHSIDDYRNLVYSEISRRK 375
9 -125.0002b9f_A mol:protein length:353 Mitogen-activated protein kinase FUS3  ali model follow..  37  4.....................RIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI-EPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPD-SFENFNEVYIIQELMQTDLHRVISQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDQQSGMTEYVATRWYRAPEVMLTSKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCSPRAREYIKSLPMYPAAPLEKMFPRV------------NPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPNDEPEGEPSFFEFDHYKEALTTKDLKKLIWNEIFS.. 353
10 -124.0003tti_A mol:protein length:464 Mitogen-activated protein kinase 10  ali model follow..  92  37...YNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMNSE 402
11 -124.0003coi_A mol:protein length:353 Mitogen-activated protein kinase 13  ali model follow..  46  3.......SLIRKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILSWHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLDKAAKSYIQSLPQTPRKDFTQLFPRA------------SPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQ-PFDDSLEHEKLTVDEWKQHIYKEIVNFS 351
12 -122.0002fsl_X mol:protein length:367 Mitogen-activated protein kinase 14  ali model follow..  47  2.......ASQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD--EMTGYVATRWYRAPEIMLNWHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISESARNYIQSLTQMPKMNFANVFIGA------------NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD--PYDQSSESRDLLIDEWKSLTYDEVISFV 350
13 -122.0003gcp_A mol:protein length:360 Mitogen-activated protein kinase 14  ali model follow..  47  1.......GSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDE--MTGYVATRWYRAPEIMLNWHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISESARNYIQSLTQMPKMNFANVFIGA------------NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD--PYDQSLESRDLLIDEWKSLTYDEVISFV 349
14 -122.0003p4k_A mol:protein length:370 Mitogen-activated protein kinase 14  ali model follow..  47  2....AAMMSQERPTFYRQELNKTIWEVPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISESARNYIQSLAQMPKMNFANVFIGA------------NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD--PYDQSFESRDLLIDEWKSLTYDEVISFV 353
15 -122.0001oz1_A mol:protein length:372 Mitogen-activated protein kinase 14  ali model follow..  47  3...RSGSMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISESARNYIQSLTQMPKMNFANVFIGA------------NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD--PYDQSFESRDLLIDEWKSLTYDEVISFV 355
16 -121.0003U8W Entity 1(prereleased)  ali follow..  47  5.....LEMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISESARNYIQSLTQMPKMNFANVFIGA------------NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD--PYDQSFESRDLLIDEWKSLTYDEVISFV 355
17 -121.0003gc8_A mol:protein length:370 Mitogen-activated protein kinase 11  ali model follow..  47  3...HMLEMSGPRAGFYRQELNKTVWEVPQRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKQALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEE--MTGYVATRWYRAPEIMLNWHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISEHARTYIQSLPPMPQKDLSSIFRGA------------NPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPEDEPEAE--PYDESVEAKERTLEEWKELTYQEVLSFK 355
18 -121.0003QYI Entity 1(prereleased)  ali follow..  39  2.........AAAAAAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRA-PTIEQMKDVYIVQDLMETDLYKLLKQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDGFLTEYVATRWYRAPEIMLNSGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCINLKARNYLLSLPHKNKVPWNRLFPNA------------DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEA-PFKFDMELDDLPKEKLKELIFEETARFQ 353
19 -121.0003e92_A mol:protein length:371 Mitogen-activated protein kinase 14  ali model follow..  46  5HHLHHHGMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISESARNYIQSLTQMPKMNFANVFIGA------------NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD--PYDQSFESRDLLIDEWKSLTYDEVISFV 360
20 -121.0001cm8_A mol:protein length:367 PHOSPHORYLATED MAP KINASE P38-GAMMA  ali model follow..  45  3......SPPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE--MTGYVVTRWYRAPEVILNWRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLSDEAKNYMKGLPELEKKDFASILTNA------------SPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQ--KYDDSFDDVDRTLDEWKRVTYKEVLSFK 352
21 -119.0002z7l_A mol:protein length:366 Mitogen-activated protein kinase 1  ali model follow..  38  2.......AMAAAAAAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRA-PTIEQMKDVYIVQDLMETDLYKLLKQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDGFLTEYVATRWYRAPEIMLNSGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCINLKARNYLLSLPHKNKVPWNRLFPNA------------DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEA-PFKFDMELDDLPKEKLKELIFEETARFQ 355
22 -119.0001wzy_A mol:protein length:368 Mitogen-activated protein kinase 1  ali model follow..  38  6...DELMAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRA-PTIEQMKDVYIVQDLMETDLYKLLKQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDGFLTEYVATRWYRAPEIMLNSGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCINLKARNYLLSLPHKNKVPWNRLFPNA------------DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEA-PFKFDMELDDLPKEKLKELIFEETARFQ 363
23 -119.0001pme_A mol:protein length:380 ERK2  ali model follow..  39  10.PRGSHMAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRA-PTIEQMKDVYLVTHLMGADLYKLLKQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHFLTEYVATRWYRAPEIMLNSGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCINLKARNYLLSLPHKNKVPWNRLFPNA------------DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEA-PFKFDMELDDLPKEKLKELIFEETARFQ 369
24 -119.0002ojg_A mol:protein length:380 Mitogen-activated protein kinase 1  ali model follow..  39  10.PRGSHMAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRA-PTIEQMKDVYIVQDLMETDLYKLLKQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDGFLTEYVATRWYRAPEIMLNSGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCINLKARNYLLSLPHKNKVPWNRLFPNA------------DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEA-PFKFDMELDDLPKEKLKELIFEETARFQ 369
25 -119.0003dt1_A mol:protein length:383 Mitogen-activated protein kinase 14  ali model follow..  47  16.....LEMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISESARNYIQSLTQMPKMNFANVFIGA------------NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD--PYDQSFESRDLLIDEWKSLTYDEVISFV 366
26 -118.0001tvo_A mol:protein length:368 Mitogen-activated protein kinase 1  ali model follow..  38  2.......AAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRA-PTIEQMKDVYIVQDLMETDLYKLLKQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDGFLTEYVATRWYRAPEIMLNSGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCINLKARNYLLSLPHKNKVPWNRLFPNA------------DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEA-PFKFDMELDDLPKEKLKELIFEETARFQ 355
27 -117.0003oht_A mol:protein length:389 p38a  ali model follow..  46  18.AAPFTMSHKERPTFYRQELNKTIWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWHYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPPASVISRMSHEARNYINSLPQMPKRNFADVFIGA------------NPLAVDLLEKMLVLDTDKRITASEALAHPYFSQYHDPDDEPESE--PYDQSFESRQLEIEEWKRLTYEEVCSFE 372
28 -117.0002i6l_A mol:protein length:320 Mitogen-activated protein kinase 6  ali model follow..  31  1..................SMNIHGFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI--VLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSLTELNSVYIVQEYMETDLANVLEGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTDLVLKIGDFGLARIMDHKGHLSEGLVTKWYRSPRLLLSPNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGI------------SREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPMDEPI................................ 320
29 -117.0002zoq_A mol:protein length:382 Mitogen-activated protein kinase 3  ali model follow..  38  21......EGVGPGVPGEVEMVKGQPFDVGPRYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKI-SPFEHQTYCQRTLREIQILLRFRHENVIGIRDILRAS-TLEAMRDVYIVQDLMETDLYKLLKQQLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHFLTEYVATRWYRAPEIMLNSGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCINMKARNYLQSLPSKTKVAWAKLFPKS------------DSKALDLLDRMLTFNPNKRITVEEALAHPYLEQYYDPTDEPVAEE-PFTFAMELDDLPKERLKELIFQETARFQ 375
30 -113.0003nie_A mol:protein length:429 MAP2 kinase  ali model follow..  33  2........SSGRENLYFQGAIIKNVKVPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLHDLIIPE-DLLKFDELYIVLEIADSDLKKLFKIFLTEQHVKTILYNLLLGEKFIHESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKQLTSHVVTRWYRAPELILLQNYTNSIDIWSTGCIFAELLNMFPLFPGKSNRDQLNIIFNVIGTPPEEDLKCIKQEVIKYIKLFPTRDGIDLSKKYSSI------------SKEGIDLLESMLRFNAQKRITIDKALSHPYLKDVRKENLENFSTEKIILPFDDWMVLSETQLRYIFLKEIQSFH 407
31 -112.0003rp9_A mol:protein length:458 Mitogen-activated protein kinase  ali model follow..  33  28...QQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIP-KDVEKFDELYVVLEIADSDFKKLFRVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPEQLTGHVVTRWYRAPELILLQNYTEAIDVWSIGCIFAELLNRGPLFPGSSCRDQLNVIFNILGTPSEEDIEALKEDAKRYIRIFPKREGTDLAERFPAS------------SADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVETNATEKVRLPFNDWMNMDEPQLRYAFVKEIQRYH 443
32 -111.0003n9x_A mol:protein length:432 Phosphotransferase  ali model follow..  32  2..........SSGRENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPD-DLLKFDELYIVLEIADSDLKKLFKIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKQLTSHVVTRWYRAPELILLQNYTKSIDIWSTGCIFAELLNMFPLFPGKSNRDQLNIIFNIIGTPTEDDLKNIKPEVIKYIKLFPHRKPINLKQKYPSI------------SDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFSTKKIILPFDDWMVLSETQLRYIFLKEVQSFH 402
33 -111.0003UIB Entity 1(prereleased)  ali follow..  30  3.........QAKGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVH-FEEPAMHKLYLVTELMRTDLAQVIHDQISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSPSARDYLRSLSNVPARAWTAVVPTA------------DPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLDLTEGL--SERFHFDESVTDVYDMHKIFTAEVERFN 361
34 -111.0003pg1_A mol:protein length:362 Mitogen-activated protein kinase, putative (M  ali model follow..  30  3.........QAKGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVH-FEEPAMHKLYLVTELMRTDLAQVIHDQISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSPSARDYLRSLSNVPARAWTAVVPTA------------DPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLDLTEGL--SERFHFDESVTDVYDMHKIFTAEVERFN 361
35 -105.0001o9u_A mol:protein length:350 GLYCOGEN SYNTHASE KINASE-3 BETA  ali model follow..  26  1.........SKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ------GKAFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTALKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGADYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF--AFPQIKAHPWTKVF-----------RPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGPALFNFTTQELSSNPPLATILIPPHA.... 348
36 -105.0004agu_A mol:protein length:311 CYCLIN-DEPENDENT KINASE-LIKE 1  ali model follow..  26  1..........................MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRK------RRLHLVFEYCDHTVLHELDRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPDYYDDEVATRWYRSPELLVGDTYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTQYFSGVKIPDPEDMEPLELKFPNI------------SYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIEDLAKEHD............................. 302
37 -104.0001gng_A mol:protein length:378 GLYCOGEN SYNTHASE KINASE-3 BETA  ali model follow..  24  2.KVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTALKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGADYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF--KFPQIKAHPWTKVF-----------RPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGPALFNFTTQELSSN-PPLATILIPPHARIQ 360
38 -103.0004dit_A mol:protein length:382 Glycogen synthase kinase-3 beta  ali model follow..  24  6..VSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTALKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGADYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF--KFPQIKAHPWTKVF-----------RPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGPALFNFTTQELSSN-PPLATILIPPHARIQ 363
39 -101.0003e3p_A mol:protein length:360 Protein kinase, putative Glycogen synthase ki  ali model follow..  28  2.......PGSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV---IQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE-RDRRDIYLVMEYVPDTLHRCCRVAPPPILIKVFLFQLIRSIGCLHSVNVCHRDIKPHNVLVNADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSTDVDLYNSKGIPSNVFSDHSLKD------------AKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPATKLPNPEDLFRFLPNEIEVMSEAQKAKLVRK..... 360
40 -101.0001r0e_A mol:protein length:391 Glycogen synthase kinase-3 beta  ali model follow..  24  3......MSLSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTALKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGADYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF--KFPQIKAHPWTKVF-----------RPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGPALFNFTTQELSSN-PPLATILIPPHARIQ 356
41 -101.0003eb0_A mol:protein length:383 Putative uncharacterized protein  ali model follow..  30  2.......................LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ------DPRYKNRELDIMKVLDHVNIIKLVDYFYTTVNPSQNKYLNVIMEYVPDTLHKVLKRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGAEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTE--VRFPTLKAKDWRKILPEGT-----------PSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNPQLFNFSYELSIIPGNVLNRILPKNFSPNY 381
42 -97.3001q3d_A mol:protein length:424 GLYCOGEN SYNTHASE KINASE-3 BETA  ali model follow..  24  32..VSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTALKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGADYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF--KFPQIKAHPWTKVF-----------RPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGPALFNFTTQELSSN-PPLATILIPPHARIQ 389
43 -97.2003SAY Entity 1(prereleased)  ali follow..  24  28..VSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTALKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGADYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF--KFPQIKAHPWTKVF-----------RPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGPALFNFTTQELSSN-PPLATILIPPHARIQ 385
44 -93.7003rp0_A mol:protein length:349 Casein kinase II subunit alpha, Casein kinase  ali model follow..  21  16.......NTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL-----KPVKKKKIKREIKILENLRGPNIITLADIVKDP---VSRTPALVFEHVNNTDFKQLY-QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQYDYSLDMWSLGCMLASMIFRKPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKIELDPRFNDILGRHSRKRWERFVHSEN-------QHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYPVVKEQSQPCADNAVLSSGLTAAR.................. 349
45 -93.2003ofm_A mol:protein length:350 Casein kinase II subunit alpha`  ali model follow..  22  17.......NSLRSREYWDYEAHVPSWGNQDDYQLVRKLGRGKYSEVFEAINITNNERVVVKIL-----KPVKKKKIKREVKILENLRGTNIIKLIDTVKDP---VSKTPALVFEYINNTDFKQLY-QILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQYDYSLDMWSLGCMLASMIFRRPFFHGQDNYDQLVRIAKVLGTEELYGYLK-IDLDPHFNDILGQHSRKRWENFIHSEN-------RHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYFYPVVKEQSQPSADN-AVLSSGLTAA.................. 349
46 -92.9004aaa_A mol:protein length:331 CYCLIN-DEPENDENT KINASE-LIKE 2  ali model follow..  29  2...........GSSGVDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKK------KRWYLVFEFVDHTILDDLELGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPEVYDDEVATRWYRAPELLVGDVYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVAGVRLPEIKEREPLERRYPK------------LSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFAERFSQELQLKVQKD....................... 324
47 -92.9002pvh_A mol:protein length:352 Casein kinase II subunit alpha  ali model follow..  22  25.......NVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKIL-----KPVKKKKIKREIKILQNLCGPNIVKLLDIVRDQ----HSKTPSLIFEYVNNTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQYDYSLDMWSLGCMFAGMIFRKPFFYGHDNHDQLVKIAKVLGTDGLNAYLNKYRIEPQLEALVGRHSRKPWLKFMN-------ADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQVRAAENSRTRA.............................. 346
48 -92.6002zjw_A mol:protein length:340 Casein kinase II subunit alpha  ali model follow..  22  14ARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL-----KPVKKKKIKREIKILENLRGPNIITLADIVKDP---VSRTPALVFEHVNNTDFKQLY-QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQYDYSLDMWSLGCMLASMIFRKPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKIELDPRFNDILGRHSRKRWERFVHSEN-------QHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMG................................ 340
49 -92.4003e3b_X mol:protein length:339 Casein kinase II subunit alpha`  ali model follow..  23  22.......NSLRSREYWDYEAHVPSWGNQDDYQLVRKLGRGKYSEVFEAINITNNERVVVKIL-----KPVKKKKIKREVKILENLRGTNIIKLIDTVKDP---VSKTPALVFEYINNTDFKQLY-QILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQYDYSLDMWSLGCMLASMIFRRPFFHGQDNYDQLVRIAKVLGTEELYGYLK-IDLDPHFNDILGQHSRKRWENFIHSEN-------RHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYFYPVVKEQSQ.................................. 339
50 -90.2002w96_B mol:protein length:306 CELL DIVISION PROTEIN KINASE 4  ali model follow..  34  4............................SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEHPNVVRLMDVCATSRTDRE-IKVTLVFEHVDQDLRTYLDKGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPR----AFPPRGPRPVQSVVPE------------MEESGAQLLLEMLTFNPHKRISAFRALQHSYLHK......................................... 294
51 -88.8003g33_A mol:protein length:308 Cell division protein kinase 4  ali model follow..  34  9............................SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGG-LPISTVREVALLRRLEHPNVVRLMDVCATSRTDRE-IKVTLVFEHVDQDLRTYLDKGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPR----AFPPRGPRPVQSVVPE------------MEESGAQLLLEMLTFNPHKRISAFRALQHSYLHK......................................... 302
52 -88.3003mi9_A mol:protein length:351 Cell division protein kinase 9  ali model follow..  24  17............................SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAS-RCKGSIYLVFDFCEHDLAGLLSNKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSQPNRYTNRVVTLWYRPPELLLGERYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYV----------RDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSDLKGMLSTHLTSMFEYLAPPRRK............. 345
53 -88.3003nup_A mol:protein length:307 Cell division protein kinase 6  ali model follow..  34  11............................QQYECVAEIGEGAYGKVFKARDLKGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLEHPNVVRLFDVCTVSRTDRE-TKLTLVFEHVDQDLTTYLDKGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR---QAFHSKSAQPIEKFVTD------------IDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ.......................................... 301
54 -88.1001ob3_A mol:protein length:288 CELL DIVISION CONTROL PROTEIN 2 HOMOLOG  ali model follow..  33  2............................EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK------KRLVLVFEHLDQDLKKLLDVGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRYTHEIVTLWYRAPDVLMGSKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT-ELPKYDPNFTVYEPLPWESFLKG------------LDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE......................................... 286
55 -87.1001bi7_A mol:protein length:326 CYCLIN-DEPENDENT KINASE 6  ali model follow..  32  11............................QQYECVAEIGEGAYGKVFKARDLKGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLEHPNVVRLFDVCTVSRTDRE-TKLTLVFEHVDQDLTTYLDKGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR---QAFHSKSAQPIEKFVTD------------IDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKENLDSHLPPSQNTSE..................... 322
56 -87.1002qkr_A mol:protein length:313 Cdc2-like CDK2/CDC28 like protein kinase  ali model follow..  36  15............................EKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSE------RCLTLVFEFMEKDLKKVLDEGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRYTHEVVTLWYRAPDVLMGSKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPG------------FCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDPQ..................................... 304
57 -86.5001vyw_A mol:protein length:309 CELL DIVISION PROTEIN KINASE 2  ali model follow..  34  7............................ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK------LYLVFEFLHQDLKKFMDAGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRYTHEVVTLWYRAPEILLGCKYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-SMPDYKPSFPKWARQDFSKVVPP------------LDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRLE.............................. 304
58 -86.2001gii_A mol:protein length:298 CELL DIVISION PROTEIN KINASE 2  ali model follow..  35  2............................ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK------LYLVFEHVHQDLKTFMDAGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRYTHEVVTLWYRAPEILLGCKYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-SMPDYKPSFPKWARQDFSKVVPP------------LDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL................................. 296
59 -85.7003pxf_A mol:protein length:306 Cell division protein kinase 2  ali model follow..  35  10............................ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK------LYLVFEFLHQDLKKFMDAGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRYTHEVVTLWYRAPEILLGCKYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-SMPDYKPSFPKWARQDFSKVVPP------------LDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL................................. 304
60 -85.7003QL8 Entity 1(prereleased)  ali follow..  35  10............................ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK------LYLVFEFLHQDLKKFMDAGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRYTHEVVTLWYRAPEILLGCKYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-SMPDYKPSFPKWARQDFSKVVPP------------LDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL................................. 304
61 -83.6002pk9_A mol:protein length:317 Cyclin-dependent protein kinase PHO85  ali model follow..  27  1........................MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPST-AIREISLMKELKHENIVRLYDVIHTE------NKLTLVFEFMDNDLKKYMDSGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNFSSEVVTLWYRAPDVLMGSRYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT-KLPKYNPNIQQRPPRDLRQVLQPHT-------KEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHASMGGSRS............................. 311
62 -82.6001ua2_A mol:protein length:346 Cell division protein kinase 7  ali model follow..  29  10............................KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK------SNISLVFDFMETDLEVIIKDVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRYTHQVVTRWYRAPELLFGARYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD--YVTFKSFPGIPLHHIFSA------------AGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLPRPNCPVETLKEQSNPALAIK.......... 328
63 -82.4001h4l_A mol:protein length:292 CELL DIVISION PROTEIN KINASE 5  ali model follow..  34  2............................QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD------KKLTLVFEFCDQDLKKYFDSDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRYSAEVVTLWYRPPDVLFGAKYSTSIDMWSAGCIFAELANARPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT-KLPDYKPYPMYPATTSLVNVVPK------------LNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP..................................... 292
64 -81.8003mtl_A mol:protein length:324 Cell division protein kinase 16  ali model follow..  29  2............................ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGA-PCTAIREVSLLKDLKHANIVTLHDIIHTE------KSLTLVFEYLDKDLKQYLDDIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKYDNEVVTLWYRPPDILLGSTYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPR------------LDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHK.................................. 294
65 -81.2003gbz_A mol:protein length:329 Kinase, CMGC CDK  ali model follow..  32  28............................DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHN------HRLHLIFEYAENDLKKYMDKDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVS-VLKIGDFGLARAFGIPIRFTHEIITLWYRPPEILLGSRYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVT-ALPDWKQSFPKFRGKTLKRVLG-----------ALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDFD..................................... 322
66 -70.5003rgf_A mol:protein length:405 Cyclin-dependent kinase 8  ali model follow..  27  20............................DLFEYECKVGRGTYGHVYKAKDGKDDKDYALKQI----EGTGISMSACREIALLRELKHPNVISLQKVFLSHAD----RKVWLLFDYAEHDLWHIIKFQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGE-RVKIADMGFARLFNSPADLDPVVVTFWYRAPELLLGARYTKAIDIWAIGCIFAELLTSEPIFHCRQHHDQLDRIFNVMGFPADKDWEDIK-KMPEHSTLMKDFRRNTYTNCSLIK---YMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPTSDVFAG.............................. 350
67 -61.5003anq_A mol:protein length:368 Dual specificity tyrosine-phosphorylation-reg  ali model follow..  27  33..........................WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN---KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTVSLNLTRKFAQQMCTALLFLATPSIIHCDLKPENILLPKRSAIKIVDFGSS--CQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADEGTNTS................................ 368
68 -60.2001how_A mol:protein length:373 SERINE/THREONINE-PROTEIN KINASE YMR216C  ali model follow..  25  20.............................RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVNDADILKLLDHFNHKGP--NGVHVVMVFEVLGENLLALIKRGIPLIYVKQISKQLLLGLDYMHRCGIIHTDIKPENVLMEILIQIKIADLGNA--CWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKD......................................... 339
69 -59.9002vx3_A mol:protein length:382 DUAL SPECIFICITY TYROSINE-PHOSPHORYLATION- RE  ali model follow..  28  46..........................WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN---KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTVSLNLTRKFAQQMCTALLFLATLSIIHCDLKPENILLPKRSAIKIVDFGSS--CQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADE..................................... 376
70 -59.7003cek_A mol:protein length:313 Dual specificity protein kinase TTK  ali model follow..  25  22............................RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQDKIIRLYDYEITD------QYIYMVMECGNIDLNSWLKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTVKDSQVGTVNYMPPEAIKDMKISPKSDVWSLGCILYYMTYGKT--PFQQIINQISKLHAIIDPNHEIEFPDI-------------------------------------PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTT............................ 305
71 -59.3001z57_A mol:protein length:339 Dual specificity protein kinase CLK1  ali model follow..  25  12..........................LSARYEIVDTLGEGAFGKVVECIDHKAGRHVAVKIVKN---VDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQNPDIKVVDFGSA--TYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKS..................................... 338
72 -58.7003k2l_A mol:protein length:429 Dual specificity tyrosine-phosphorylation-reg  ali model follow..  27  89..........................VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN---EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQRSGIKVIDFGSS--CYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRR......................................... 408
73 -57.6003qd2_B mol:protein length:332 Eukaryotic translation initiation factor 2-al  ali model follow..  21  6............................TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLP-NRELAREKVMREVKALAKLEHPGIVRYFNTVGQLQPSSPKVYLYIQMQLCRKNLKDWMNRRREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQ-------------------------------------------MERVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL........................................ 332
74 -57.5002wu6_A mol:protein length:381 DUAL SPECIFICITY PROTEIN KINASE CLK3  ali model follow..  23  43..........................LQERYEIVGNLGEGTFGKVVECLDHARGKSVALKIIRN---VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSTSIRVADFGSA--TFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHT............................... 375
75 -57.4003llt_A mol:protein length:360 Serine/threonine kinase-1, PfLammer  ali model follow..  20  27..........................LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN---IKKYTRSAKIEADILKKIQNNNIVKYHGKFM--------DHMCLIFEPLGPSLYEIITRNFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDSTGIKLIDFGCA--TFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDEWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE.......................................... 354

FFAS is supported by the NIH grant R01-GM087218-01
5 9 9 5 2   jobs submitted since Jan 1, 2011
Comments and questions to: webmaster
Locations of visitors to this page
Selected papers from Godzik Lab
Ying Zhang, Ines Thiele, Dana Weekes, Zhanwen Li, Lukasz Jaroszewski, Krzysztof Ginalski, Ashley Deacon, John Wooley, Scott Lesley, Ian Wilson, Bernhard Palsson, Andrei Osterman, Adam Godzik. Three-Dimensional Structural View of the Central Metabolic Network of Thermotoga maritima. Science. 2009 Sep 18;325(5947):1544-9.

Alexey M. Eroshkin, Andrew LeBlanc, Dana Weekes, Kai Post, Zhanwen Li, Akhil Rajput, Sal T. Butera, Dennis R. Burton, Adam Godzik. bNAber: database of broadly neutralizing HIV antibodies. Nucl. Acids Res. 2013; published on November 7, 2013.

Jaroszewski L, Rychlewski L, Godzik A. Improving the quality of twilight-zone alignments. Protein Sci. 2000 Aug;9(8):1487-96.